Paracetamol Misuse and Dental Pain: Results from the French Observational DAntaLor Study
- PMID: 30703177
- DOI: 10.11607/ofph.1861
Paracetamol Misuse and Dental Pain: Results from the French Observational DAntaLor Study
Abstract
Aims: To evaluate the risk of hepatotoxicity due to unintentional paracetamol misuse in patients with acute dental pain.
Methods: A prospective multicenter observational survey was performed in patients consulting, without appointment, the odontology departments of three main French hospitals in the Lorraine region over a 3-month period. Patients were asked to fill out a medical questionnaire while seated in the waiting room. Those who completed the questionnaire, had dental pain, and took paracetamol were included in the DAntaLor study. Misuse was defined as a daily dose of more than 4 g of paracetamol per day. The risk of hepatotoxicity was considered high if the supposed ingested dose was above the threshold of 150 mg.kg-1.24h-1, 125 mg.kg-1.24h-1, or 100 mg.kg1.24h-1 over periods of 24, 48, and 72 hours, respectively. Hepatotoxicity was suspected in the presence of clinical symptoms.
Results: Of the 1,810 patients consulting the odontology departments, 741 were included in the study. Painkillers were used in 74.4% of the cases, and paracetamol was taken by 81.7%. Paracetamol was self-medicated in 85.5% of the patients and misused by 6.0%. Clinical symptoms were observed in 1.6% of the patients with no paracetamol misuse. For patients consuming more than 4 g per day and experiencing mild unspecific clinical symptoms of hepatotoxicity, the suspected ingested dose category was below one of the three previously defined thresholds for 11.8% and was above for 40.0%.
Conclusion: Patients with dental pain are at risk of paracetamol overdose and hepatotoxicity.
Comment in
-
What Is the Optimal Dose of Predniso(lo)ne for Induction of Remission in Patients With Autoimmune Hepatitis?Clin Gastroenterol Hepatol. 2020 Jul;18(8):1896-1897. doi: 10.1016/j.cgh.2019.02.032. Epub 2019 Feb 23. Clin Gastroenterol Hepatol. 2020. PMID: 30807845 No abstract available.
-
Reply.Clin Gastroenterol Hepatol. 2020 Jul;18(8):1897-1898. doi: 10.1016/j.cgh.2020.01.038. Epub 2020 Feb 1. Clin Gastroenterol Hepatol. 2020. PMID: 32017986 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical